<sup>18</sup>F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?

<sup>18</sup>F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?

Background: To investigate and compare the diagnostic performance of <sup>18</sup>F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) PET/MR and MR alone in whole-body primary staging and restaging of patients with rectal cancer. Methods: A retrospective analysis was performed to evalu...

Full description

Bibliographic Details
Main Authors: Yan Li, Laura Isabel Mueller, Jan Peter Neuhaus, Stefanie Bertram, Benedikt Michael Schaarschmidt, Aydin Demircioglu, Johannes Maximilian Ludwig, Julian Kirchner, Christoph Rischpler, Ken Herrmann, Onofrio Antonio Catalano, Lale Umutlu
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
rectal cancer
diagnosis
positron-emission tomography
PET
PET/MR
hybrid imaging
Online Access:https://www.mdpi.com/2077-0383/9/10/3163

Internet

https://www.mdpi.com/2077-0383/9/10/3163

Similar Items